Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary

Autor: Meredith Leston, William H Elson, Conall Watson, Anissa Lakhani, Carole Aspden, Clare R Bankhead, Ray Borrow, Elizabeth Button, Rachel Byford, Alex J Elliot, Xuejuan Fan, Uy Hoang, Ezra Linley, Jack Macartney, Brian D Nicholson, Cecilia Okusi, Mary Ramsay, Gillian Smith, Sue Smith, Mark Thomas, Dan Todkill, Ruby SM Tsang, William Victor, Alice J Williams, John Williams, Maria Zambon, Gary Howsam, Gayatri Amirthalingam, Jamie Lopez-Bernal, F D Richard Hobbs, Simon de Lusignan

Publikováno v: JMIR Public Health and Surveillance, Vol 8, Iss 12, p e39141 (2022)

BackgroundThe Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) is one of Europe’s oldest sentinel systems, working with the UK Health Security Agency (UKHSA) and its predecessor bodies for 55 years. Its su

Externí odkaz: https://doaj.org/article/100e40db390b46799dd7de19913026e2

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021:a national vaccine surveillance platform self-controlled case series study

Autor: Ruby SM Tsang, Mark Joy, Rachel Byford, Chris Robertson, Sneha N Anand, William Hinton, Nikhil Mayor, Debasish Kar, John Williams, William Victor, Ashley Akbari, Declan T Bradley, Siobhan Murphy, Dermot O’Reilly, Rhiannon K Owen, Antony Chuter, Jillian Beggs, Gary Howsam, Aziz Sheikh, FD Richard Hobbs, Simon de Lusignan

Publikováno v: Tsang, R SM, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O’Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & Lusignan, S D 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021 : a national vaccine surveillance platform self-controlled case series study ', Eurosurveillance, vol. 28, no. 3 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Tsang, R SM, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O'Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & de Lusignan, S 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021 : a national vaccine surveillance platform self-controlled case series study ', Eurosurveillance, vol. 28, no. 3 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Tsang, R S, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O'Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & de Lusignan, S 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study ', EUROSURVEILLANCE, vol. 28, no. 3, 2200195 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195

Background Post-authorisation vaccine safety surveillance is well established for reporting common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 vaccines. Aim To estimate the incidence of AEIs presenting to prim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605363ab9da8612afeb7c2fa34e6153e
https://research-information.bris.ac.uk/ws/files/367996381/eurosurv_28_3_4.pdf